The Medicalisation of Wellness: Balancing Innovation, Evidence and Trust

24 Feb 2027
Main stage
Diagnostics, biomarker testing, GLP-1 support, hormone health and longevity services are pushing wellness businesses into increasingly clinical territory. This session explores where operators should draw the line, when clinical expertise and partnerships become necessary, and how to expand into higher-value health services while protecting credibility, consumer trust and the business itself.